Chile vs Ecuador: Treatment success rate for patients treated for MDR-TB
Chile
64.0%
in 2022
Ecuador
65.0%
in 2022
Chile rank
116th
Ecuador rank
113th
Treatment success rate for patients treated for MDR-TB over time
- Chile
- Ecuador
How they compare
Ecuador currently reports 65.0% against 64.0% in Chile, a difference of 1.0%.
The two have swapped places 7 times across 16 shared years of data; in 2002 it was Chile ahead.
Chile ranks 116th and Ecuador ranks 113th of 163 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Ecuador in 2.
Head to head by decade
| Decade | Chile | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.2% | 57.5% | 21.3% | Ecuador |
| 2010s | 44.0% | 48.7% | 4.7% | Ecuador |
| 2020s | 59.0% | 53.0% | 6.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chile or Ecuador?
- Ecuador, at 65.0% against 64.0% in Chile as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chile and Ecuador?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Chile and Ecuador?
- 16 years are reported by both, from 2002 to 2022.
- How do Chile and Ecuador rank globally for treatment success rate for patients treated for mdr-tb?
- Chile ranks 116th and Ecuador ranks 113th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.